Innovative Thinking

We’ve compiled these resources and articles that reflect our commitment to emerging technology and healthcare trends.

September 14, 2026

One Year of The Compound Blog: 12 Lessons That Shaped Better Sterile Compounding

Over the past year, we've explored training, contamination control, environmental monitoring, hazardous drug safety, competency assessment, and operational excellence.

August 3, 2026

Should Compounders Sanitize Their Gloves During a Media-Fill Test?

Should compounders sanitize gloves during a media-fill test? Learn how realistic competency assessments support aseptic technique and USP <797> compliance.

July 7, 2026

USP <797>: Where Compliance Breaks Down—and How to Close the Gap

USP <797> provides a comprehensive framework for sterile compounding—but it does not function as an operational playbook. Most organizations are not struggling because they are unaware of the requirements. They struggle in the space between what the chapter says and what daily practice actually looks like.

June 1, 2026

USP <797> Contamination Control: Where Best Practices Make the Difference

USP <797> sets clear expectations for preventing contamination in sterile compounding—but compliance alone doesn’t guarantee control. True contamination control depends on how consistently best practices are applied in daily operations, especially in three high impact areas: garbing and hand hygiene, material transfer, and cleanroom behavior.

May 1, 2026

USP <797> Table 2 vs. Table 3: What’s the Difference — and Why It Matters for Ongoing Competency

Viable air and surface sampling are often treated as a second thought. Results are reviewed, levels are checked, and the program moves on until there’s exceeded an action level. But USP <797> never intended viable monitoring to be a passive exercise.

April 1, 2026

Viable Air and Surface Sampling Under USP <797>: What the Data Is Meant to Tell You

Viable air and surface sampling are often treated as a second thought. Results are reviewed, levels are checked, and the program moves on until there’s exceeded an action level. But USP <797> never intended viable monitoring to be a passive exercise.

March 2, 2026

USP <800> Wipe Sampling: Why It Matters—and How to Implement It Without Fear

For many sterile compounding teams, hazardous drug (HD) wipe sampling is one of the most intimidating aspects of USP <800>. Even organizations with strong sterile compounding programs often delay implementation—not because they don’t care about safety, but because they’re unsure what wipe sampling will uncover, how results will be interpreted, or how regulators will respond.

February 2, 2026

USP <797> & <800> in Practice: A 5-Step Playbook for Calm, Consistent Compounding

Sterile compounding standards are designed to protect patients and the people who prepare their medications. Yet many pharmacies still experience “compliance whiplash”—surges of activity before audits, followed by drift during normal operations.

1 2 3 Next »